216 related articles for article (PubMed ID: 18300214)
1. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
Buchini S; Buschiazzo A; Withers SG
Angew Chem Int Ed Engl; 2008; 47(14):2700-3. PubMed ID: 18300214
[No Abstract] [Full Text] [Related]
2. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
Amaya MF; Watts AG; Damager I; Wehenkel A; Nguyen T; Buschiazzo A; Paris G; Frasch AC; Withers SG; Alzari PM
Structure; 2004 May; 12(5):775-84. PubMed ID: 15130470
[TBL] [Abstract][Full Text] [Related]
4. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
5. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
6. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
[TBL] [Abstract][Full Text] [Related]
7. alpha-2,3-sialyllactitol is a donor substrate for Trypanosoma cruzi trans-sialidase.
Previato JO
Glycobiology; 2004 Oct; 14(10):25G; author reply 26G. PubMed ID: 15382323
[No Abstract] [Full Text] [Related]
8. Trypanosoma cruzi Trans-sialidase: structural features and biological implications.
Oliveira IA; Freire-de-Lima L; Penha LL; Dias WB; Todeschini AR
Subcell Biochem; 2014; 74():181-201. PubMed ID: 24264246
[TBL] [Abstract][Full Text] [Related]
9. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
10. Continuous fluorimetric assay for high-throughput screening of inhibitors of trans-sialidase from Trypanosoma cruzi.
Neres J; Buschiazzo A; Alzari PM; Walsh L; Douglas KT
Anal Biochem; 2006 Oct; 357(2):302-4. PubMed ID: 16930524
[No Abstract] [Full Text] [Related]
11. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
12. Effect of primary structure modifications in Trypanosoma cruzi neuraminidase/trans-sialidase activities.
Cremona ML; Pollevick GD; Frasch AC; Campetella O
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):697-702. PubMed ID: 8832101
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
14. A sialidase mutant displaying trans-sialidase activity.
Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile.
Watts AG; Damager I; Amaya ML; Buschiazzo A; Alzari P; Frasch AC; Withers SG
J Am Chem Soc; 2003 Jun; 125(25):7532-3. PubMed ID: 12812490
[TBL] [Abstract][Full Text] [Related]
16. The chemistry and biology of trypanosomal trans-sialidases: virulence factors in Chagas disease and sleeping sickness.
Schauer R; Kamerling JP
Chembiochem; 2011 Oct; 12(15):2246-64. PubMed ID: 21956798
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
19. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
20. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]